Relay Therapeutics is a clinical-stage, small molecule precision
medicine company developing potentially life-changing therapies for
patients living with cancer and genetic disease.
- It reported third quarter 2025 financial results today, including a net loss of $74.1 million, and announced the appointment of Lonnel Coats and Habib Dable to its Board of Directors.
** charts before earnings **
** after earnings **
No comments:
Post a Comment